Page last updated: 2024-11-01

norfloxacin and Renal Artery Stenosis

norfloxacin has been researched along with Renal Artery Stenosis in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research Excerpts

ExcerptRelevanceReference
" The mean serum elimination half-life was 8."1.27[Human and animal studies on the pharmacokinetics of norfloxacin in renal failure]. ( Akaba, K; Irikura, T; Kusajima, H; Miyahara, T; Saito, A; Shimada, J; Uchida, H, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimada, J1
Saito, A1
Akaba, K1
Miyahara, T1
Kusajima, H1
Uchida, H1
Irikura, T1

Other Studies

1 other study available for norfloxacin and Renal Artery Stenosis

ArticleYear
[Human and animal studies on the pharmacokinetics of norfloxacin in renal failure].
    The Japanese journal of antibiotics, 1986, Volume: 39, Issue:10

    Topics: Administration, Oral; Adult; Aged; Animals; Bile; Female; Half-Life; Humans; Injections, Intravenous

1986